Pfizer Inc

NYSE: PFE
$23.05
+$0.13 (+0.6%)
Closing Price on April 28, 2025

PFE Stock Chart and Intraday Price

PFE Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 235 E 42ND ST, NEW YORK, NY, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 150,147.88M USD
Shares Outstanding 5,646,780,000
Pfizer Inc. is a global leader in biopharmaceuticals, offering a wide range of medicines and vaccines. The company focuses on various therapeutic areas including cardiovascular, infectious diseases, women’s health, chronic immune and inflammatory diseases, and more. Pfizer is known for its significant contributions to COVID-19 prevention and treatment with products like Comirnaty and Paxlovid. It also has a strong portfolio in biosimilars and innovative treatments across other serious health conditions. Founded in 1849 and based in New York, Pfizer collaborates with several other healthcare giants to improve global health.

PFE Articles

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so. Trading at $852 per...
As income and wealth inequality continue to divide Americans into two distinct classes and levels of wealth, those who are struggling to find investments that can outpace inflation and the growing...
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor...
Shares of cloud-based storage solutions provider Snowflake Inc. (NYSE: SNOW) have endured a difficult month, falling -9.10% alongside the broad market’s continued downturn. However, over the past...
Shares of Pfizer (NYSE: PFE) have been battered over the past month, falling by -16.44%, outpacing the market’s loss of -9.44% over the same period. Since hitting its one-year high on July 30,...
2025 hasn’t been kind to investors amid rising concerns about a recession and tariffs. There is a lot of uncertainty surrounding the economy, and this has impacted the stock market. But smart...
The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has a reputation for being the go-to choice for income-focused investors who want both quality and yield. The ETF offers a 4.14% dividend yield,...
The good news for investors seeking high-yield dividend stocks to buy right now is that there are a number of top options for investors to consider in the high-yield dividend world. Outside of much...
April is turning out to be a tumultuous month as President Trump’s sweeping tariffs on U.S. trading partners is creating chaos and confusion. The on-again, off-again nature of the import levies (a...
With trade war volatility off the charts, investors are hunting for safety in safe dividend stocks. That’s because dividend stocks can help smooth out the ride when markets drop. Plus, companies...
Yesterday’s wild rally in the stock market where $5.5 trillion in value following President Trump hitting a 90-day pause on his tariffs, exemplifies the dramatic swings investors have experienced...
These five well-known stocks were beaten down following the recent selling but will remain attractive long after the tariff selling and profit-taking are over.
Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
Some on Wall Street now advise selling any rally in U.S. markets. However, these four high-yield dividend stocks are keepers. 
The stock market has been a wild roller coaster ride for the past five years, shifting from bull market to bear and back numerous times. It was a good lesson that stocks don’t just rise in a...